Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone-induced thyroid dysfunction in clinical practice.

S Ursella1, A Testa, M Mazzone

  • 1Department of Emergency Medicine, Catholic University of the Sacred Heart, Policlinico A. Gemelli, Rome, Italy. steura@hotmail.com

European Review for Medical and Pharmacological Sciences
|November 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the efficacy of a Propionibacterium extract gel in wound healing and symptom relief after open excisional hemorrhoidectomy: a randomized clinical study.

Techniques in coloproctology·2026
Same author

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same author

Tailor's bunion (bunionette): current concepts and outcomes of open versus minimally invasive surgery.

Musculoskeletal surgery·2026
Same author

Prior Incarceration and Dental Insurance Trajectories throughout Older Adulthood.

JDR clinical and translational research·2025
Same author

Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024
Same journal

Assessment of the acceptability of effervescent oxycodone/paracetamol in the management of moderate-to-severe pain: the FirAlgos study.

European review for medical and pharmacological sciences·2026
Same journal

Development of a new diagnostic tool for detecting cervical cancer using a TCR-like antibody targeting the HPV 16 oncoprotein E7.

European review for medical and pharmacological sciences·2026
Same journal

Clinical characteristics, management strategies, and outcomes of pediatric immune thrombocytopenic purpura: a five-year single-center experience.

European review for medical and pharmacological sciences·2026
Same journal

Author Correction: Efficacy of intravenous lipid emulsion as an adjunctive therapy for acute aluminum phosphide poisoning: a randomized, open-label, pilot clinical trial.

European review for medical and pharmacological sciences·2026
Same journal

Publisher Correction: The three biological gaps and hyperoxaluria in ethylene glycol poisoning: case presentation and review.

European review for medical and pharmacological sciences·2026
Same journal

Retraction Note: Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study.

European review for medical and pharmacological sciences·2026
See all related articles

Amiodarone, an anti-arrhythmic drug, can cause thyroid dysfunction, including thyrotoxicosis (AIT) and hypothyroidism (AIH). This review examines thyroid test alterations, epidemiology, and treatment for these amiodarone-induced conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Amiodarone is a critical Class III anti-arrhythmic medication for various cardiac rhythm disorders.
  • Amiodarone significantly impacts thyroid function by inhibiting 5'-deiodinase, altering triiodothyronine (T3) and thyroxine (T4) metabolism.
  • This drug can precipitate overt thyroid dysfunction, namely amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH).

Purpose of the Study:

  • To review alterations in thyroid function tests in patients treated with amiodarone.
  • To analyze the epidemiology of amiodarone-induced thyroid dysfunction (AIT and AIH).
  • To discuss available treatment options for AIT and AIH.

Main Methods:

  • Literature review of current scientific publications.

Related Experiment Videos

  • Analysis of thyroid laboratory test results in euthyroid patients on amiodarone.
  • Examination of epidemiological data and treatment strategies for AIT and AIH.

    • Main Results:

    • Amiodarone causes characteristic changes in thyroid tests, including decreased T3 generation and increased reverse T3 (rT3).
    • Overt thyroid dysfunction (AIT or AIH) occurs in a subset of patients, with distinct underlying mechanisms and geographical prevalence.
    • AIT, more prevalent in iodine-deficient areas, is challenging to manage and often necessitates amiodarone withdrawal.
    • AIH, common in iodine-sufficient regions, relates to impaired thyroid hormone production or coexisting Hashimoto's thyroiditis.

    Conclusions:

    • Amiodarone treatment frequently alters thyroid function tests, requiring careful monitoring.
    • Amiodarone-induced thyrotoxicosis and hypothyroidism present unique clinical and etiological profiles.
    • Management strategies differ significantly between AIT and AIH, with AIT often requiring amiodarone discontinuation.